Morgan Stanley lowered the firm’s price target on Axon (AXON) to $600 from $675 and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon price target lowered to $674 from $690 at Piper Sandler
- Axon price target raised to $755 from $750 at JPMorgan
- Axon Earns Buy Rating on Robust ARR Growth, AI-Driven Demand, and Underappreciated Profitability
- Axon price target lowered to $675 from $800 at Baird
- Axon price target lowered to $440 from $570 at UBS